Catalyst Wire Dossier Catalyst Wire Dossier

COBENFY

Xanomeline and Trospium Chloride · E.R. Squibb & Sons, L.L.C.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for COBENFY, covering 2024-09-26 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia [Phase 1, Phase 2]

See pricing